Methylcobalamin Injectable Recall Due to Facility Sterility Assurance Failure
Pharmacy Innovations is recalling injectable methylcobalamin products in multiple strengths due to lack of sterility assurance. FDA inspection revealed insanitary facility conditions that compromise product safety.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of injectable pharmaceutical products with a manufacturing defect (insanitary facility conditions) that compromises sterility assurance. Injectable products must be sterile to be safe; this recall represents a risk-of-harm situation. No illnesses or injuries are reported in the source.
Plain-English summary
Pharmacy Innovations, located in Erie, Pennsylvania, is recalling multiple injectable methylcobalamin products that were distributed nationwide. The recalled products include methylcobalamin 3 mg/ml, 5 mg/ml (in 0.2 ml and 1 ml vials), 12.5 mg/ml, and 25 mg/ml formulations. These are prescription-only injectable medications.
The recall was initiated due to lack of assurance of sterility. During an FDA inspection of the manufacturing facility, insanitary conditions were identified. Because these are injectable products that must be sterile to ensure patient safety, the insanitary facility conditions create a risk that products may be contaminated or lose their sterility.
Patients and healthcare providers who have these products in use or storage should contact Pharmacy Innovations or consult their healthcare provider regarding this recall. Healthcare professionals should determine the appropriate action for patients who may have received these recalled products.
The recalled product
- Product
- METHYLCOBALAMIN 12.5MG/ML (1ML VIAL) INJECTABLE METHYLCOBALAMIN 25MG/ML (1.2ML VIAL) INJECTABLE; METHYLCOBALAMIN 3MG/ML (1ML VIAL) INJECTABLE; METHYLCOBALAMIN 5MG/ML (0.2ML VIAL) INJECTABLE; METHYLCOBALAMIN 5MG/ML (1ML VIAL) INJECTABLE; METHYLCOBALAMIN-PF- 12.5MG/ML (1ML VIAL) IN
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Injectable / Vitamin B12
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Pharmacy Innovations under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Pharmacy Innovations
See all →- HighEdetate Disodium Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable Hydroxocobalamin Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighFDA Recalls Acetylcysteine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable vitamin B-complex products recalled for lack of sterility assurance
FDA (Drugs) · 2023-02-01
- HighDexamethasone Injectable and Ophthalmic Products Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22